Search Result

Pathways Recommended:	Antibody-drug Conjugate/ADC Related

Results for "

CD27 Antibody

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Drug Derivative (1) Influenza Virus (1) NF-κB (1) TNF Receptor (8) Transmembrane Glycoprotein (2)
By Research Areas:	Cancer (6) Inflammation/Immunology (7)

Inhibitors & Agonists

Inhibitory Antibodies

Antibodies

Targets Recommended: ADC Antibody Antibody-Drug Conjugates (ADCs) ADC Linker PROTAC-Linker Conjugates for PAC

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P99057A

Varlilumab (anti-CD27) CDX-1127 (anti-CD27)	TNF Receptor Transmembrane Glycoprotein	Inflammation/Immunology Cancer
Varlilumab (CDX-1127) (anti-CD27) is an agonist *anti-CD27* monoclonal antibody. Varlilumab (anti-CD27) can promote T cell expansion and activate the immune response. Varlilumab (anti-CD27) has anti-tumor activity and can be used in the research of hematological malignancies and solid tumors .

HY-P990018

Boserolimab MK-5890	TNF Receptor NF-κB	Inflammation/Immunology Cancer
Boserolimab (MK-5890) is a humanized agonist monoclonal antibody that binds to CD27 to provide a costimulatory signal that enhances T-cell–mediated responses .

HY-P99057

Varlilumab CDX-1127	TNF Receptor Transmembrane Glycoprotein	Inflammation/Immunology Cancer
Varlilumab (CDX-1127) is an agonist *anti-CD27* monoclonal antibody. Varlilumab can promote T cell expansion and activate the immune response. Varlilumab has anti-tumor activity and can be used in the research of hematological malignancies and solid tumors .

HY-113512

17-HDHA	Influenza Virus	Inflammation/Immunology
17-HDHA is a DHA-derived specialized proresolving mediator (SPM). 17-HDHA enhances the antibody-mediated immune response against influenza virus. 17-HDHA enhances the differentiation of B cells toward the CD27 ⁺ CD38 ⁺ antibody-secreting cell phenotype, thereby strongly increasing IgM and IgG production by activated B cells .

HY-P990280

Anti-Mouse CD27 Antibody (RM27-3E5)	TNF Receptor	Others
Anti-Mouse CD27 Antibody (RM27-3E5) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD27.

HY-P991465

*Anti-CD27* Antibody (M2177)**	TNF Receptor	Cancer
Anti-CD27 Antibody (M2177) is a human monoclonal antibody (mAb) targeting *TNFRSF7/CD27. Anti-CD27* Antibody (M2177) inhibits the binding of sCD70 to human CD27 ECD-Fc. Anti-CD27 Antibody (M2177) can be used in the study of anti-tumor immunity. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P991466

*Anti-CD27* Antibody (M2191)**	TNF Receptor	Cancer
Anti-CD27 Antibody (M2191) is a human monoclonal antibody (mAb) targeting *TNFRSF7/CD27. Anti-CD27* Antibody (M2191) inhibits the binding of sCD70 to human CD27 ECD-Fc. Anti-CD27 Antibody (M2191) can be used in the study of anti-tumor immunity. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P990528

Anti-TNFRSF7/CD27 Antibody	TNF Receptor	Inflammation/Immunology
Anti-TNFRSF7/CD27 Antibody is a CHO-expressed human antibody targeting *TNFRSF7/CD27. The Anti-TNFRSF7/CD27* Antibody contains huIgG2 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-TNFRSF7/CD27 Antibody can refer to Human IgG2 kappa, Isotype Control (HY-P99002).

HY-P991063

GEN-1053 BNT-313; Tixestobart	TNF Receptor	Inflammation/Immunology Cancer
GEN-1053 (BNT-313) is a fully human IgG1 antibody that targets CD27. GEN-1053 binds to CD27 and forms a hexamer upon binding. The isotype control for GEN-1053 can refer to Human IgG1 lambda1, Isotype Control (HY-P99992) .

HY-120255

17(R)-HDHA 17(R)-HDoHE	Drug Derivative	Inflammation/Immunology
17(R)-HDHA (17(R)-HDoHE) is a pro-resolving mediator (SPM). 17(R)-HDHA enhances the differentiation of B cells toward the CD27(+)CD38(+) antibody-secreting cell phenotype, thereby strongly increasing IgM and IgG production by activated B cells. 17(R)-HDHA does not affect cell proliferation and is non-toxic to cells .

Cat. No.	Product Name	Target	Research Area

HY-P99057A

Varlilumab (anti-CD27) CDX-1127 (anti-CD27)	TNF Receptor Transmembrane Glycoprotein	Inflammation/Immunology Cancer
Varlilumab (CDX-1127) (anti-CD27) is an agonist *anti-CD27* monoclonal antibody. Varlilumab (anti-CD27) can promote T cell expansion and activate the immune response. Varlilumab (anti-CD27) has anti-tumor activity and can be used in the research of hematological malignancies and solid tumors .

HY-P990018

Boserolimab MK-5890	TNF Receptor NF-κB	Inflammation/Immunology Cancer
Boserolimab (MK-5890) is a humanized agonist monoclonal antibody that binds to CD27 to provide a costimulatory signal that enhances T-cell–mediated responses .

HY-P99057

Varlilumab CDX-1127	TNF Receptor Transmembrane Glycoprotein	Inflammation/Immunology Cancer
Varlilumab (CDX-1127) is an agonist *anti-CD27* monoclonal antibody. Varlilumab can promote T cell expansion and activate the immune response. Varlilumab has anti-tumor activity and can be used in the research of hematological malignancies and solid tumors .

HY-P990280

Anti-Mouse CD27 Antibody (RM27-3E5)	TNF Receptor	Others
Anti-Mouse CD27 Antibody (RM27-3E5) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD27.

HY-P991465

*Anti-CD27* Antibody (M2177)**	TNF Receptor	Cancer
Anti-CD27 Antibody (M2177) is a human monoclonal antibody (mAb) targeting *TNFRSF7/CD27. Anti-CD27* Antibody (M2177) inhibits the binding of sCD70 to human CD27 ECD-Fc. Anti-CD27 Antibody (M2177) can be used in the study of anti-tumor immunity. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P991466

*Anti-CD27* Antibody (M2191)**	TNF Receptor	Cancer
Anti-CD27 Antibody (M2191) is a human monoclonal antibody (mAb) targeting *TNFRSF7/CD27. Anti-CD27* Antibody (M2191) inhibits the binding of sCD70 to human CD27 ECD-Fc. Anti-CD27 Antibody (M2191) can be used in the study of anti-tumor immunity. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P990528

Anti-TNFRSF7/CD27 Antibody	TNF Receptor	Inflammation/Immunology
Anti-TNFRSF7/CD27 Antibody is a CHO-expressed human antibody targeting *TNFRSF7/CD27. The Anti-TNFRSF7/CD27* Antibody contains huIgG2 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-TNFRSF7/CD27 Antibody can refer to Human IgG2 kappa, Isotype Control (HY-P99002).

HY-P991063

GEN-1053 BNT-313; Tixestobart	TNF Receptor	Inflammation/Immunology Cancer
GEN-1053 (BNT-313) is a fully human IgG1 antibody that targets CD27. GEN-1053 binds to CD27 and forms a hexamer upon binding. The isotype control for GEN-1053 can refer to Human IgG1 lambda1, Isotype Control (HY-P99992) .

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P81664

	CD70 Antibody (YA1409) CD70; CD27LG; TNFSF7; TNFSF7G; CD27L	FC, ELISA	Human
	CD70 Antibody (YA1409) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1409), targeting CD70. CD70 Antibody (YA1409) can be used for FC, ELISA experiment in human background.

HY-P85815

	CD27 Antibody (YA5507)	WB, ICC/IF, ELISA	Human
	CD27 Antibody (YA5507) is a mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to CD27. It can be applicated for WB, ICC/IF, ELISA assays, in the background of human.

HY-P84981

	CD27 Antibody (YA4673) CD 27 Antibody; CD27 Antibody; CD27 antigen Antibody; CD27 molecule Antibody; CD27_HUMAN Antibody; CD27L receptor Antibody; LPFS2 Antibody; MGC20393 Antibody; OTTHUMP00000238557 Antibody; S152 Antibody; T cell activation antigen CD27 Antibody; T cell antivation antigen S152 Antibody; T-cell activation antigen CD27 Antibody; T14 Antibody; TNFRSF 7 Antibody; TNFRSF7 Antibody; TNFSF7 Antibody; Tp 55 Antibody; Tp55 Antibody; Tumor necrosis factor receptor superfamily member 7 Antibody; CD27 nanobody	FC, ELISA	Human
	CD27 Antibody (YA4673) is a mouse-derived and non-conjugated monoclonal antibody, targeting to CD27. It can be applicated for FC, ELISA assays, in the background of human.

HY-P85859

	CD27 Antibody (YA5551) CD 27 Antibody; CD27 Antibody; CD27 antigen Antibody; CD27 molecule Antibody; CD27_HUMAN Antibody; CD27L receptor Antibody; LPFS2 Antibody; MGC20393 Antibody; OTTHUMP00000238557 Antibody; S152 Antibody; T cell activation antigen CD27 Antibody; T cell antivation antigen S152 Antibody; T-cell activation antigen CD27 Antibody; T14 Antibody; TNFRSF 7 Antibody; TNFRSF7 Antibody; TNFSF7 Antibody; Tp 55 Antibody; Tp55 Antibody; Tumor necrosis factor receptor superfamily member 7 Antibody; CD27 nanobody;	FC, ELISA	Human
	CD27 Antibody (YA5551) is a mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CD27. It can be applicated for FC, ELISA assays, in the background of human.

HY-P81533

	CD27 Antibody (YA1278) CD27; CD27L receptor; LPFS2; S152; T14; TNFRSF7; TNFSF7; Tp55	IHC-P	Human
	CD27 Antibody (YA1278) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1278), targeting CD27. CD27 Antibody (YA1278) can be used for IHC-P experiment in human background.

HY-P85005

	CD70 Antibody (YA4697) CD70; CD27L; CD27LG; TNFSF7; CD70 antigen; CD27 ligand; CD27-L; Tumor necrosis factor ligand superfamily member 7; CD antigen CD70; CD70 nanobody	ELISA, FC	Human
	CD70 Antibody (YA4697) is a mouse-derived and non-conjugated monoclonal antibody, targeting to CD70. It can be applicated for ELISA, FC assays, in the background of human.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.